Amicus Therapeutics Ownership | Who Owns Amicus Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Amicus Therapeutics Ownership Summary

Amicus Therapeutics is owned by 49.78% institutional investors, 0.77% insiders, and 49.45% retail investors. Vanguard group is the largest institutional shareholder, holding 9.60% of FOLD shares. Vanguard Health Care Inv is the top mutual fund, with 6.99% of its assets in Amicus Therapeutics shares.

FOLD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Amicus Therapeutics	49.78%	0.77%	49.45%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	29.26M	9.60%	$275.62M
Wellington management group llp	28.46M	9.34%	$268.11M
Blackrock funding, inc. /de	27.91M	9.16%	$262.89M
Blackrock	24.37M	8.05%	$241.77M
Perceptive advisors	24.25M	7.96%	$228.40M
Avoro capital advisors	23.18M	7.61%	$218.31M
William blair investment management	15.60M	5.12%	$146.93M
State street	10.36M	3.40%	$97.60M
Palo alto investors lp	7.66M	2.51%	$72.18M
Jpmorgan chase	7.21M	2.37%	$67.96M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Palo alto investors lp	7.66M	11.18%	$72.18M
Perceptive advisors	24.25M	6.29%	$228.40M
Redmile group	7.05M	4.63%	$66.46M
Cm management	450.00K	3.79%	$4.24M
Avoro capital advisors	23.18M	3.09%	$218.31M
Prosight management, lp	920.00K	2.40%	$8.67M
Vestal point capital, lp	3.35M	1.87%	$31.56M
Sovereign's capital management	297.83K	1.79%	$2.81M
Healthinvest partners ab	326.84K	1.46%	$3.08M
Old west investment management	380.24K	1.45%	$3.58M

Top Buyers

Holder	Shares	% Assets	Change
Wellington management group llp	28.46M	0.05%	4.50M
Vestal point capital, lp	3.35M	1.87%	3.35M
Norges bank	3.08M	0.00%	3.08M
Blackrock funding, inc. /de	27.91M	0.01%	1.80M
Orbimed advisors	2.29M	0.44%	1.72M

Top Sellers

Holder	Shares	% Assets	Change
Jpmorgan chase	7.21M	0.01%	-5.71M
Morgan stanley	4.99M	0.00%	-4.71M
Perceptive advisors	24.25M	6.29%	-3.81M
Janus henderson group	3.40M	0.02%	-2.94M
Assenagon asset management	476.78K	0.01%	-1.56M

New Positions

Holder	Shares	% Assets	Change	Value
Vestal point capital, lp	3.35M	1.87%	3.35M	$31.56M
Norges bank	3.08M	0.00%	3.08M	$29.03M
Prosight management, lp	920.00K	2.40%	920.00K	$8.67M
Intrinsic edge capital management	673.90K	0.77%	673.90K	$6.35M
Sovereign's capital management	297.83K	1.79%	297.83K	$2.81M

Sold Out

Holder	Change
Quadrant capital group	-14.00
Federated hermes	-28.00
Cva family office	-43.00
Capital performance advisors llp	-43.00
Innealta capital	-47.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	144	-52.32%	151,685,331	-50.57%	49	0.49%	60	-59.46%	59	-35.16%
Sep 30, 2024	300	12.78%	306,793,850	-2.57%	100	0.93%	149	5.67%	90	20.00%
Jun 30, 2024	266	1.53%	314,899,506	-0.72%	103	0.95%	141	6.01%	75	-6.25%
Mar 31, 2024	262	7.82%	317,196,449	-0.45%	104	0.89%	133	-0.75%	80	26.98%
Dec 31, 2023	243	-0.41%	318,631,655	7.59%	108	1.08%	134	3.08%	63	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	20.89M	6.99%	2.30M
Vanguard Total Stock Mkt Idx Inv	9.40M	3.06%	7.43K
Vanguard US Total Market Shares ETF	9.38M	3.05%	10.28K
iShares Russell 2000 ETF	7.68M	2.50%	-66.55K
Vanguard Small Cap Index	7.63M	2.48%	6.21K
Delaware Small Cap Core I	5.13M	1.73%	-31.80K
Macquarie Small Cap Core I	4.79M	1.56%	-
Janus Henderson US Opportunistic Alpha	4.58M	1.54%	-565.02K
Janus Henderson Opportunistic Alpha MA	4.58M	1.54%	4.58M
Vanguard Small Cap Growth Index Inv	4.28M	1.39%	-31.82K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 19, 2025	Campbell Bradley L	President and CEO	Sell	$4.00K
Dec 02, 2024	Campbell Bradley L	President and CEO	Sell	$75.12K
Nov 06, 2024	Campbell Bradley L	President and CEO	Sell	$98.80K
Nov 01, 2024	Campbell Bradley L	President and CEO	Sell	$85.96K
Oct 01, 2024	Campbell Bradley L	President and CEO	Sell	$79.49K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	1
2024 Q4	-	4
2024 Q3	-	4
2024 Q2	-	3
2024 Q1	-	22

FOLD Ownership FAQ

Who Owns Amicus Therapeutics?

Amicus Therapeutics shareholders are primarily institutional investors at 49.78%, followed by 0.77% insiders and 49.45% retail investors. The average institutional ownership in Amicus Therapeutics's industry, Biotech Stocks , is 68.48%, which Amicus Therapeutics falls below.

Who owns the most shares of Amicus Therapeutics?

Amicus Therapeutics’s largest shareholders are Vanguard group (29.26M shares, 9.60%), Wellington management group llp (28.46M shares, 9.34%), and Blackrock funding, inc. /de (27.91M shares, 9.16%). Together, they hold 28.10% of Amicus Therapeutics’s total shares outstanding.

Does Blackrock own Amicus Therapeutics?

Yes, BlackRock owns 8.05% of Amicus Therapeutics, totaling 24.37M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.77M$. In the last quarter, BlackRock increased its holdings by 1.52M shares, a 6.66% change.

Who is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested, with 11.18% of its assets in 7.66M Amicus Therapeutics shares, valued at 72.18M$.

Who is the top mutual fund holder of Amicus Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Amicus Therapeutics shares, with 6.99% of its total shares outstanding invested in 20.89M Amicus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools